Rapid Detection of SARS-CoV-2 Using Reverse transcription RT-LAMP method
preprint
OA: closed
AI-generated summary
A rapid, one-step RT-LAMP assay detected SARS-CoV-2 RNA within 30 minutes with sensitivity similar to RT-PCR and 99% specificity in clinical specimens.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Corona Virus Disease 2019 (COVID-19) is a recently emerged life-threatening disease caused by SARS-CoV-2. Real-time fluorescent PCR (RT-PCR) is the clinical standard for SARS-CoV-2 nucleic acid detection. To detect SARS-CoV-2 early and control the disease spreading on time, a faster and more convenient method for SARS-CoV-2 nucleic acid detecting, RT-LAMP method (reverse transcription loop-mediated isothermal amplification) was developed. RNA reverse transcription and nucleic acid amplification were performed in one step at 63 °C isothermal conditions, and the results can be obtained within 30 minutes. ORF1ab gene, E gene and N gene were detected at the same time. ORF1ab gene was very specific and N gene was very sensitivity, so they can guarantee both sensitivity and specificity for SARS-CoV-2. The sensitivity of RT-LAMP assay is similar to RT-PCR, and specificity was 99% as detecting 208 clinical specimens. The RT-LAMP assay reported here has the advantages of rapid amplification, simple operation, and easy detection, which is useful for the rapid and reliable clinical diagnosis of SARS-CoV-2.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (12)
- doi:10.1038/s41423-020-0372-4 via crossref
- doi:10.2807/1560-7917.es.2020.25.3.2000045 via crossref
- doi:10.1016/s0140-6736(20)30251-8 via crossref
- doi:10.1016/s0140-6736(20)30154-9 via crossref
- doi:10.1002/jmv.25721 via crossref
- doi:10.1016/j.toxicon.2016.03.019 via crossref
- doi:10.5812/jjm.37171 via crossref
- doi:10.1373/clinchem.2004.032011 via crossref
- doi:10.1128/jcm.42.5.1956-1961.2004 via crossref
- doi:10.1093/nar/28.12.e63 via crossref
- doi:10.1128/jcm.41.9.4359-4365.2003 via crossref
- doi:10.1128/jcm.41.6.2616-2622.2003 via crossref
Source provenance
- crossref
- last seen: 2026-07-23T06:52:51.314493+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-28T06:55:22.213180+00:00